Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 7/20 | 0.36 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PAX2 | Q02962 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL974960 | 1.00 | LMNA (0.36) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL25616299 | 0.90 | PAX2 (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL25616316 | 0.90 | PAX2 (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL5183012 | 0.88 | LMNA (0.34) | LMNAALDH1A1SMN1; SMN2PDE2ATSHR | |
| SCHEMBL14416878 | 0.88 | PDE2A (0.37) | LMNAALDH1A1SMN1; SMN2PDE2ATSHR | |
| SCHEMBL974937 | 0.88 | KDM1A (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AHSD17B10 | |
| SCHEMBL4817224 | 0.88 | ALDH1A1 (0.34) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL8916786 | 0.88 | TSHR (0.40) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL4821987 | 0.88 | TSHR (0.40) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL23925376 | 0.87 | EGLN2 (0.46) | PDE2AEGLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | claimed |
| US-6297251-B1 | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID CO. | 2001-10-02 | — | — | US | claimed |
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | claimed |
| US-7329663-B2 | Substituted-triazolopyrimidines as anticancer agents | WYETH (US) | 2008-02-12 | — | — | US | disclosed |
| EP-1307200-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | Wyeth (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | AMERICAN HOME PRODUCTS CORPORATION | 2002-06-06 | — | — | US | disclosed |
| WO-2002002563-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | WYETH (US) | 2002-01-10 | — | — | WO | disclosed |
| US-6297251-B1 | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID CO. | 2001-10-02 | — | — | US | disclosed |
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | disclosed |
| US-6117876-A | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0975634-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046607-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068744-A1 | Substituted-triazolopyrimidines as anticancer agents | TUBB3, TUBA1C, TUBB1 | LMNA 2723/4885ALDH1A1 2231/4885SMN1; SMN2 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.